Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology
19h agoen
Source
bignewsnetwork.comReliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technologybignewsnetwork.comNew Delhi [India], July 7 (ANI): Strand Life Sciences, a subsidiary of Reliance Industries Limited, has been granted an Indian patent for its integrated platform that enables early cancer detection from a simple blood test using cell-free DNA (cfDNA) analysis, the company said in a press release on Tuesday. The patented platform combines high-quality genome sequencing, rigorous quality control, biologically infor
You might also wanna read
ED raids ex-Samajwadi Party MLA Deep Narayan, his associates in UP
bignewsnetwork.com·6h ago
Rudraprayag Police intensify 'Operation Cyber Suraksha' to provide relief to fraud victims
bignewsnetwork.com·6h ago
Wayanad landslide: Road connectivity restored, rescue operations intensify as search for missing continues
bignewsnetwork.com·6h ago
"Equally party to crime.": Bengaluru Police Commissioner on arrest of whistleblower in IT firm crche case
bignewsnetwork.com·6h ago
Pain of displacement ends as Naxal-affected families return to Narayanpur's Balebeda
bignewsnetwork.com·6h ago
IMD forecasts heavy rain, strong winds over Mumbai; waterlogging disrupts Western Railway Services
bignewsnetwork.com·6h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.